FDA Again Aims To Keep Misconduct Probes Secret

Law360, New York (July 2, 2013, 1:38 PM EDT) -- The U.S. Food and Drug Administration on Monday reissued a rule that will keep documents related to misconduct investigations of researchers under wraps and protect confidential sources, just six months after the agency pulled the original rule amid stiff opposition.

The rule will exempt certain material from investigations into FDA employees, agents and contractors for misconduct, including data falsification, fabrication or plagiarism, from Privacy Act disclosure requirements. While the agency pulled the rule after receiving at least one strong objection during the comment period, it says...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.